YOKNEAM, Israel, Dec. 26 /PRNewswire-FirstCall/ -- Lumenis(R) Ltd. (LUME.PK), a global manufacturer and seller of laser and light-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications, announced today the shipment of its 150th Lumenis One system, a significant milestone for the company. The Lumenis One is a sophisticated platform for aesthetic light and laser treatments designed to meet physician needs. Lumenis began shipping Lumenis One in May 2004 and has provided thousands of IPL systems since it first introduced IPL technology to the market in 1995.
Lumenis One represents the fourth generation of IPL technology and reinforces Lumenis' place at the forefront of innovation. Optimizing and building upon a firm foundation, Lumenis One unites three gold standard technologies on one multi-technology and multi-application platform: Intense Pulsed Light for skin photorejuvenation and treating vascular and pigmented lesions, the LightSheer(R) diode laser for hair removal and the Multi-Spot Nd:YAG for treating leg veins and deeper vascular lesions. The system's key features include Optimal Pulse Technology (OPT), numerous presets, easy custom settings, and an intuitive touch-screen software interface. These enable Lumenis One to provide increased patient comfort, faster treatments and easily tracked patient information.
Avner Raz, President and Chief Executive Officer, said, "Shipping the 150th Lumenis One clearly illustrates our firm commitment to product excellence. As the market leader, Lumenis invests heavily in research and development for all our products -- more than $10 million in the first nine months of 2004 alone. We design products to satisfy the specific needs of our customers and provide direct benefit to their patients. As a result, customer demand for Lumenis One is strong, as evidenced by the large number of systems sold."
Physicians who have purchased Lumenis One during the last year are quick to praise its benefits citing patient satisfaction, speed and cost effectiveness among the key advantages. Dr. Dore Gilbert of Newport Beach, California said, "When my patients look in the mirror, they are so happy -- they see that the treatments have removed years from their appearance." "Lumenis One's greatest advantage is speed. Doing hair removal, we used to shy away from large areas, like backs, but now that's no problem," said Dr. Jeffrey Hunt of Tampa, Florida.
"The (special feature) Patient Database has saved me significant time and money. It's great to be able to get all treatment parameters, as well as medical records that help the operator go to advanced settings quickly. The Database should be on every system," stated Dr. Corey Maas of San Francisco, California.
About Lumenis
Lumenis is a global developer, manufacturer and seller of laser and light- based devices for medical, aesthetic, ophthalmic, dental and veterinary applications. The Company offers a wide range of products along with extensive product support systems including training, education and service. Lumenis invests heavily in research and development to maintain and enhance its leading industry position. The Company holds numerous patents worldwide on its technologies. For more information about Lumenis and its products, log onto http://www.lumenis.com/
Investors: Lauri Hanover 1-866-232-6803 972-4-959-9122
The statements in this press release that are not historical facts are forward-looking statements which are subject to risks and uncertainties. The Company's actual results could differ materially from those anticipated in the forward looking statements based on a variety of factors, including, among others: uncertainties with respect to market acceptance of the Company's products, the implementation and outcome of our Turnaround Plan, obtaining regulatory approvals for new products or for the sale of existing products in new markets and enforcement of intellectual property rights; risks associated with competition and competitive pricing pressures, economic conditions generally, the Company's international operations and the Company's ability to integrate its operations with those of acquired businesses; the outcome of the Securities and Exchange Commission investigation and several securities class action lawsuits to which the Company is subject and the outcome of the investigation conducted by the Audit Committee; uncertainties relating to the Company's continuing liquidity; and other risks detailed from time to time in the reports filed by Lumenis with the SEC, including its annual report on Form 10-K and quarterly reports on Form 10-Q.
Lumenis Ltd.
Lumenis One represents the fourth generation of IPL technology and reinforces Lumenis' place at the forefront of innovation. Optimizing and building upon a firm foundation, Lumenis One unites three gold standard technologies on one multi-technology and multi-application platform: Intense Pulsed Light for skin photorejuvenation and treating vascular and pigmented lesions, the LightSheer(R) diode laser for hair removal and the Multi-Spot Nd:YAG for treating leg veins and deeper vascular lesions. The system's key features include Optimal Pulse Technology (OPT), numerous presets, easy custom settings, and an intuitive touch-screen software interface. These enable Lumenis One to provide increased patient comfort, faster treatments and easily tracked patient information.
Avner Raz, President and Chief Executive Officer, said, "Shipping the 150th Lumenis One clearly illustrates our firm commitment to product excellence. As the market leader, Lumenis invests heavily in research and development for all our products -- more than $10 million in the first nine months of 2004 alone. We design products to satisfy the specific needs of our customers and provide direct benefit to their patients. As a result, customer demand for Lumenis One is strong, as evidenced by the large number of systems sold."
Physicians who have purchased Lumenis One during the last year are quick to praise its benefits citing patient satisfaction, speed and cost effectiveness among the key advantages. Dr. Dore Gilbert of Newport Beach, California said, "When my patients look in the mirror, they are so happy -- they see that the treatments have removed years from their appearance." "Lumenis One's greatest advantage is speed. Doing hair removal, we used to shy away from large areas, like backs, but now that's no problem," said Dr. Jeffrey Hunt of Tampa, Florida.
"The (special feature) Patient Database has saved me significant time and money. It's great to be able to get all treatment parameters, as well as medical records that help the operator go to advanced settings quickly. The Database should be on every system," stated Dr. Corey Maas of San Francisco, California.
About Lumenis
Lumenis is a global developer, manufacturer and seller of laser and light- based devices for medical, aesthetic, ophthalmic, dental and veterinary applications. The Company offers a wide range of products along with extensive product support systems including training, education and service. Lumenis invests heavily in research and development to maintain and enhance its leading industry position. The Company holds numerous patents worldwide on its technologies. For more information about Lumenis and its products, log onto http://www.lumenis.com/
Investors: Lauri Hanover 1-866-232-6803 972-4-959-9122
The statements in this press release that are not historical facts are forward-looking statements which are subject to risks and uncertainties. The Company's actual results could differ materially from those anticipated in the forward looking statements based on a variety of factors, including, among others: uncertainties with respect to market acceptance of the Company's products, the implementation and outcome of our Turnaround Plan, obtaining regulatory approvals for new products or for the sale of existing products in new markets and enforcement of intellectual property rights; risks associated with competition and competitive pricing pressures, economic conditions generally, the Company's international operations and the Company's ability to integrate its operations with those of acquired businesses; the outcome of the Securities and Exchange Commission investigation and several securities class action lawsuits to which the Company is subject and the outcome of the investigation conducted by the Audit Committee; uncertainties relating to the Company's continuing liquidity; and other risks detailed from time to time in the reports filed by Lumenis with the SEC, including its annual report on Form 10-K and quarterly reports on Form 10-Q.
Lumenis Ltd.
© 2004 PR Newswire
